Pharmaceutical Price Regulation Scheme

(asked on 6th July 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans to undertake an assessment of the effect on smaller companies of any changes introduced in the next Pharmaceutical Price Regulation Scheme.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 16th July 2018

The Government is committed to supporting the United Kingdom life sciences industry and ensuring that patients can access cost-effective innovative medicines and technologies at a price the National Health Service can afford. We have been listening to industry feedback and discussing how the medicines market is likely to evolve over the next five years. These discussions have now moved into a more formal phase and are commercially sensitive. The Government will update Parliament if and when agreement is reached.

Reticulating Splines